Matrix metalloproteinases and their inhibitors in gingival mast cells in persons with and without human immunodeficiency virus infection

Journal of Periodontal Research

Volumn 38, Issue 6, 2003, Pages 575-582

  Naesse E P ^a   Schreurs, O ^a   Helgeland, K ^a   Schenck, K ^a   Steinsvoll, S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Human immunodeficiency virus; Mast cells; Matrix metalloproteinases; Periodontitis

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRYPTASE;

ARTICLE; CONTROLLED STUDY; FEMALE; GINGIVA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; MAST CELL; PERIODONTITIS; PROTEIN EXPRESSION; STAINING;

ADULT; CHRONIC DISEASE; FEMALE; GINGIVA; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INFLAMMATION MEDIATORS; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; SERINE ENDOPEPTIDASES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TRYPTASES;

EID: 0345166873     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2003.00687.x     Document Type: Article

References (62)

1. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;33:235-249.
2. Zachrisson BU, Schultz-Haudt SD. A comparative histological study of clinically normal and chronically inflamed gingivae from the same individuals. Odontol Tidskr 1968;6:179-192.
3. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
4. Nilsson G, Metcalfe DD. Contemporary issues in mast cell biology. Allergy Asthma Proc 1996;17:59-63.
5. Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
6. Abraham SN, Arock M. Mast cells and basophils in innate immunity. Semin Immunol 1998;10:373-381.
7. Lin T-J, Befus AD. Mast cells and eosinophils in mucosal defenses and pathogenesis. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal immunology. San Diego: Academic Press, 1999: 469-482.
8. Myint M, Steinsvoll S, Yuan ZN, Johne B, Helgeland K, Schenck K. Highly increased numbers of leukocytes in inflamed gingiva from patients with HIV infection. AIDS 2002;16:235-243.
9. Galli SJ. Mast cells and basophils. Curr Opin Hematol 2000;7:32-39.
10. Winkler JR, Robertson PB. Periodontal disease associated with HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992;73:145-150.
11. Yeung SC, Stewart GJ, Cooper DA, Sindhusake D. Progression of periodontal disease in HIV seropositive patients. J Periodontol 1993;64:651-657.
12. Holmstrup P, Westergaard J. Periodontal diseases in HIV-infected patients. J Clin Periodontol 1994;21:270-280.
13. Lamster IB, Grbic JT, Bucklan RS, Mitchell-Lewis D, Reynolds HS, Zambon JJ. Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 1997;3:141-148.
14. Lamster IB, Grbic JT, Mitchell-Lewis D, Begg MD, Mitchell A. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 1998;3:62-75.
15. Robinson PG. Which periodontal changes are associated with HIV infection? J Clin Periodontol 1998;25:278-285.
16. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4: 197-250.
17. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
18. Parsons SL, Watson SA, Brown PD, Collins HM, Steele RJ. Matrix metalloproteinases. Br J Surg 1997;84:160-166.
19. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 1998;78:1495-1502.
20. McCawley LJ, Matrisian LM Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000;6:149-156.
21. Martignetti JA, Aqeel AA, Sewairi WA et al. Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 2001;28:261-265.
22. Vu TH. Don't mess with the matrix. Nat Genet 2001;28:202-203.
23. Wielockx B, Lannoy K, Shapiro SD et al. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat Med 2002;7: 1202-1208.
24. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR. Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem 1990;265: 6318-6322.
25. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-557.
26. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD. Negative regulation of gene expression by TGF-beta. Mol Reprod Dev 1992;32:111-120.
27. Tonetti MS, Freiburghaus K, Lang NP, Bickel M. Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodont Res 1993;28: 511-513.
28. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophils-and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 1994;102:342-349.
29. Westerlund U, Ingman T, Lukinmaa PL et al. Human neutrophils gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996; 75:1553-1563.
30. Tervahartiala T, Pirila E, Ceponis A et al. The in vivo expression of collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000;79:1969-1977.
31. Center for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992;41:1-19.
32. Løe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-616.
33. Ramfjord SP. The periodontal disease index (PDI). J Periodontol 1967;38: 602-610.
34. Odden K, Schenck K, Hurlen B. High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection. J Oral Path Med 1995;24:413-419.
35. Kennett CN, Cox SW, Eley BM. Ultrastructural localization of cathepsin B in gingival tissue from chronic periodontitis patients. Histochem J 1997;29:727-734.
36. 1 in chronically-inflamed periodontal tissue. J Clin Periodontol 1999;26:366-373.
37. Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinases A and B is regulated by kit-ligand and TGF-beta. J Immunol 1999;162:5528-5535.
38. Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1998;18:1707-1715.
39. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000;289:1202-1206.
40. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbec U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245-257.
41. Chapel C, Camara V, Clayette P et al. Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures. Biochem Biophys Res Commun 1994;204: 1272-1278.
42. Dhawan S, Wahl LM, Heredia A et al. Interferon-gamma inhibits HIV-induced invasiveness of monocytes. J Leukoc Biol 1995;58:713-716.
43. Weeks BS, Klotman ME, Holloway E, Stetler-Stevenson WG, Kleinman HK, Klotman PE. HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. AIDS Res Hum Retroviruses 1993;9:513-518.
44. Mellanen L, Ingman T, Lahdevirta J et al. Matrix metalloproteinases-1, -3, and -8 and myeloperoxidase saliva of patients with human immunodeficiency virus infection. Oral Dis 1996;2:263-271.
45. Mellanen L, Salo T, Ingman T, Konttinen YT, Lahdevirta J, Sorsa T. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Acta Odontol Scand 1998;56: 135-142.
46. Marras D, Bruggeman LA, Gao F et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med 2002;5:522-526.
47. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997;77:1033-1079.
48. Segal DM, Taurog JD, Metzger H. Dimeric immunoglobulin E serves as a unit for mast cell degranulation. Proc Natl Acad Sci USA 1977;74:2993-2998.
49. Nakamura T, Fonteh AN, Hubbard WC et al. Arachidonic acid metabolism during antigen and ionophore activation of the mouse bone marrow-derived mast cell. Biochem Biophys Acta 1991;1085:191-200.
50. Gordon JR, Galli S. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990;346:274-276.
51. Myint M, Odden K, Schreurs O, Halstensen TS, Schenck K. The gingival plasma cell infiltrate in HIV-positive patients is disorganized. J Clin Periodontol 1999;26:358-365.
52. Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ. J Immunol 2000;164:4332-4339.
53. Tkaczyk C, Okayama Y, Woolhiser MR, Hagaman DD, Gilfillan AM, Metcalfe DD. Activation of human mast cells through the high affinity IgG receptor. Mol Immunol 2001;38:1289-1293.
54. Redegeld FA, van der Heijden MW, Kool M et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nat Med 2002;8:694-701.
55. Sandholm L, Saxen L. Local immunoglobulin synthesis in juvenile and adult periodontitis. J Clin Periodontol 1984;11:459-466.
56. Short LL, Zoellner H, Hunter N. Extraction of amyloid-like fibrils from chronically inflamed periodontal tissues. J Oral Pathol Med 1994;23:358-363.
57. Supajatura V, Ushio H, Nakao A et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 2002;109:1351-1359.
58. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-549.
59. Naukkarinen A, Harvima I, Paukkonen K, Aalto ML, Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 1993;285:341-346.
60. Scott DT, Lam FY, Ferrell WR. Acute joint inflammation - mechanisms and mediators. Gen Pharmacol 1994;25:1285-1296.
61. Lowman MA, Benyon RC, Church MK. Characterization of neuropeptide- induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988;95:121-130.
62. Bunker CB, Cerio R, Bull HA, Evans J. Dowd PM, Foreman JC. The effect of capsaicin application on mast cells in normal human skin. Agents Actions 1991;33:195-196.